@ToxSci
The September 2017, Vol. 159, Issue of Toxicological Sciences includes a wide range of articles on topics certain to be of great interest and importance to you. In this issue, ToxSci Editor-in-Chief (EIC) Gary W. Miller addresses the expansive mission of ToxSci to publish the most influential research in toxicology, ranging from new and novel findings to confirmatory data that “also contain new insights.”
“There seems to be a misperception that Toxicological Sciences only accepts articles that are mechanistic in nature. Although we certainly publish many outstanding articles that help elucidate molecular mechanisms, our mission is to publish the most influential research in the field of toxicology. Risk assessment, product and drug safety, toxicokinetic modeling, systematic production, and analysis of –omic scale data, all of these areas are essential for the field of toxicology and we welcome such submissions. That said, we are unapologetic for our standards of quality, rigor, and reproducibility and we do want exciting and, dare I say, novel findings in the field. We do have a bias toward new and novel findings, as new information is more likely to drive the field forward. We do, however, publish quite a bit of confirmatory data within articles that also contain new insights. For examples, I encourage you to Look Inside ToxSci for the most influential research in the field of toxicology. "
Also as you Look Inside ToxSci, you will find four Editor's Highlights prepared by ToxSci Associate Editors and EIC Dr. Miller as follows: Lucio G. Costa on Mouse Embryonic Stem Cells for Developmental Toxicity, Ruth A. Roberts on DNA Decoy Drug Safety, Dr. Miller on Rotenone and Nrlp3-Mediated Inflammation, and Nathan J. Cherrington on Adverse Outcome Pathway for Hepatic Steatosis.
The mission of ToxSci, the official journal of the Society of Toxicology, is to publish the most influential research in the field of toxicology.